AD
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK.
Lancet 377(9772):1149; author reply 1149-50 (2011) PMID 21459202
DOI: 10.1016/S0140-6736(11)60455-8
Version: za2963e q8zab q8zb6 q8zcb q8zd7 q8zed q8zfd q8zg9
AD
Lancet 377(9772):1149; author reply 1149-50 (2011) PMID 21459202
DOI: 10.1016/S0140-6736(11)60455-8
ANZ J Surg (2013) PMID 23647832
Int J Radiat Oncol Biol Phys 86(2):213 (2013) PMID 23642621
J Health Soc Behav (2013) PMID 23653312